Literature DB >> 14574456

A novel transfecting peptide comprising a tetrameric nuclear localization sequence.

Wolfgang Ritter1, Christian Plank, James Lausier, Carsten Rudolph, Daniela Zink, Dietrich Reinhardt, Joseph Rosenecker.   

Abstract

The transport of exogenous DNA into the nucleus of eukaryotic cells is a prerequisite for successful gene delivery. To favor nuclear transport we synthesized a tetramer of the nuclear localization signal (NLS) of the SV40 large T-antigen as a novel nonviral gene delivery vector. This 4.4-kDa lysine-rich peptide (NLSV404) binds and compacts DNA by electrostatic interaction and forms stable polyplexes. Apart from its sequence-specific potency to mediate nuclear accumulation of conjugated albumin, NLSV404 also displays properties of nuclear transport for plasmid DNA as confirmed by fluorescence in situ hybridization. Further, NLSV404 polyplexes are shown to efficiently transfect various cell lines such as 16HBE14o-, HeLa S6, and Cos7 cells. NLSV404 polyplexes displayed at least 20-fold higher transfection rates than analogous polyplexes formed by the nuclear transport-deficient mutant sequence cNLS. Using growth-arrested cells, NLSV404 complexes were at least 100-fold more efficient than cNLS complexes. Combination of NLSV404 peptide but not of cNLS peptide with preformed polyethylenimine and dendrimer DNA complexes resulted in a strong increase in transfection efficiency. Incubation of cells prior to transfection with NLSV404 polyplexes with excess free peptide NLSV404 but not with cNLS resulted in a dose-dependent dramatic decrease in the transfection rate, suggesting a sequence-specific competitive inhibition. These results indicate that NLSV404 mediates nuclear accumulation of transfected plasmid DNA and that it can be a highly useful component of nonviral gene vectors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574456     DOI: 10.1007/s00109-003-0483-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  22 in total

1.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus.

Authors:  S Brunner; T Sauer; S Carotta; M Cotten; M Saltik; E Wagner
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

Review 2.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

3.  Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes.

Authors:  C Plank; M X Tang; A R Wolfe; F C Szoka
Journal:  Hum Gene Ther       Date:  1999-01-20       Impact factor: 5.695

4.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus.

Authors:  M A Zanta; P Belguise-Valladier; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

5.  Nuclear localization signals enhance germline transmission of a transgene in zebrafish.

Authors:  P Collas; P Aleström
Journal:  Transgenic Res       Date:  1998-07       Impact factor: 2.788

6.  Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha.

Authors:  C Ciolina; G Byk; F Blanche; V Thuillier; D Scherman; P Wils
Journal:  Bioconjug Chem       Date:  1999 Jan-Feb       Impact factor: 4.774

7.  Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes.

Authors:  J O Rädler; I Koltover; T Salditt; C R Safinya
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

8.  Nuclear location signals in polyoma virus large-T.

Authors:  W D Richardson; B L Roberts; A E Smith
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

9.  Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation.

Authors:  Sylvia Brunner; Elke Fürtbauer; Thomas Sauer; Malgorzata Kursa; Ernst Wagner
Journal:  Mol Ther       Date:  2002-01       Impact factor: 11.454

10.  Cellular and molecular barriers to gene transfer by a cationic lipid.

Authors:  J Zabner; A J Fasbender; T Moninger; K A Poellinger; M J Welsh
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

View more
  12 in total

1.  What clinicians should know about SV40 large T antigen and nucleocytoplasmic transport.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2003-11       Impact factor: 4.599

Review 2.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 3.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

Review 4.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

Review 5.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

6.  Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines.

Authors:  Jennifer C Rea; Annelise E Barron; Lonnie D Shea
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

7.  Characterization of Ku70(2)-NLS as bipartite nuclear localization sequence for non-viral gene delivery.

Authors:  Johannes Matschke; Alexander Bohla; Christof Maucksch; Rashmi Mittal; Carsten Rudolph; Joseph Rosenecker
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

8.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 9.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.

Authors:  Guanyou Lin; Richard A Revia; Miqin Zhang
Journal:  Adv Funct Mater       Date:  2020-10-13       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.